How Similar Are Biosimilars to Biologics? Part II

Through conversations with patient advocates Cristina Montoya and Lene Andersen, we learn that many of the emotions and discussions around starting (and staying on) a treatment are in fact the same for biosimilars and biologics.

In the second of a two-part episode, Cristina and Lene discuss that feeling when you know your treatment is working, the possibility of adjusting medications, and ultimately, if they feel more comfortable with biosimilars.

“One of the things that can be such a joyful part of the process is when it starts working.  And all of a sudden, you can do this thing that you haven't been able to do for months. And that's really incredible,” says Lene Andersen.

Among the highlights in this episode:

01:50- Lene and Cristina tell Zoe and Conner what injection day is like

04:21- Lene and Cristina talk about the side effects that may come on injection day

06:08- Lene and Cristina talk about the process of getting the timing of their injections correct

08:26- Zoe asks Lene and Cristina what they decide to bring up with their physician at appointments

11:01- Lene and Cristina share the moments of joy where they noticed the treatments were working

12:27- Conners asks Cristina if she is happy that she made the switch to biosimilars

13:05- Zoe asks Lene about her thoughts on biosimilars after hearing Cristina share her experience

16:03- Lene and Cristina remind the listener that the symptoms of arthritis are guaranteed, the side effects from the treatments vary

Contact Our Hosts:

Zoe Rothblatt, Associate Director, Community Outreach at GHLF: [e-mail]

Conner Mertens, Patient Advocate and Community Outreach Manager at GHLF: [e-mail]

We’d love to hear what you think. Send your comments to [e-mail]

See omnystudio.com/listener for privacy information.